相关实验视频

Updated: Jul 13, 2025

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

19.8K

对大B细胞淋巴瘤的可能的新组织学预后指数

Hideaki Nitta1, Haruko Takizawa1, Toru Mitsumori1

  • 1Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.

Journal of clinical medicine
|October 14, 2023
PubMed
概括

一个新的组织学预后指数 (HPI) 确定了大型B细胞淋巴瘤 (LBCL) 的治疗耐药性. 阴性GRP94/CYP3A4表明预后良好,而阳性GRP94/CYP3A4则表明结果不佳.

关键词:
在 CYP3A4 中.在P53中,P53是P53阿尔多 - 基因还原酶家族1成员C3 (AKR1C3)葡萄糖调节蛋白94 (GRP94) 是一种葡萄糖调节蛋白.免疫组织化学 (IHC) 染色大型B细胞淋巴瘤 (LBCL)多重耐药性蛋白1 (MDR1) 是一种多重耐药性蛋白.多重耐药性相关蛋白1 (MRP1) 是一种多重耐药性相关蛋白.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.4K
Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

8.8K

相关概念视频